1 Min Read
Oct 16 (Reuters) - Medrx Co Ltd
* Says it commenced phase I clinical trial for MRX-1OXT (oxycodone tape reagent) in the United States
Source text in Japanese: goo.gl/U1QbwL
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.